Communiqués Christian Hansen Börse Stuttgart

Actions

51C

DK0060227585

Temps Différé Börse Stuttgart Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		+2,93%	-1,82%

02/02	Novozymes et Chr. Hansen concluent un accord de fusion	MT
29/01	Novozymes finalise sa fusion avec Chr. Hansen après avoir obtenu l'enregistrement final et émis des actions B	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Completion of the combination between Novozymes and Chr. Hansen	29/01	GL
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen	26/01	GL
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted	20/12	GL
Major shareholder announcement from Burlington Loan Management DAC	19/12	GL
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained	12/12	GL
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.	20/11	GL
Managers' Transaction	02/11	GL
Christian Hansen : Q4 Conference call transcript 2022/23	13/10/23	PU
Managers' Transactions	13/10/23	GL
Christian Hansen : Q4 Investor presentation 2022/23	12/10/23	PU
Chr. Hansen Holding A/S Interim Report Q4 2022/23	12/10/23	GL
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen	10/10/23	GL
Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP	27/09/23	GL
Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion	04/09/23	GL
Christian Hansen : Q4 Aide memoire 2022/23	30/08/23	PU
Christian Hansen : Q3 Conference call transcript 2022/23	07/07/23	PU
Christian Hansen : Q3 Investor presentation 2022/23	06/07/23	PU
Chr. Hansen Holding A/S Interim Report Q3 2022/23	06/07/23	GL
Christian Hansen : Change of Management in Bacthera AG	23/06/23	PU
Christian Hansen : Chr. Hansen secures EU approval for the final HMO in its 5 HMO Mix	12/06/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Christian Hansen Börse Stuttgart

Actions

51C

DK0060227585

Communiqués

Filtres